Ocular mucous membrane pemphigoid

a review

Samanta Taurone, Marialuisa Spoletini, Massimo Ralli, Pietro Gobbi, Marco Artico, Laszlò Imre, Cecília Czakò, I. Kovács, Antonio Greco, Alessandra Micera

Research output: Contribution to journalReview article

Abstract

Ocular mucous membrane pemphigoid (MMP) is a rare, immuno-mediated chronic progressive condition of the conjunctiva characterized by blisters developing from sub-epithelial tissue through disruption of the adhesions between the conjunctival epithelium and the sub-epithelium. Patients with ocular MMP, in many cases, develop profound conjunctival scarring and visual impairment. Furthermore, ocular MMP may lead to a progressive secondary corneal vascularization and to corneal opacification. Ocular MMP is difficult to diagnose during the initial stages because of false negatives during biopsy and variability in the clinical presentation. Most of the current pharmacological treatments aim to control the inflammatory response to reduce the progressive tissue remodeling which leads to the formation of a fibrotic scar. The course and prognosis of ocular MMP depend on the severity and progression of the disease after systemic immunomodulatory therapy. The aim of this review is to provide a comprehensive analysis of the current literature on established and emerging concepts in ocular MMP, with special attention to its clinical presentation, diagnosis, treatment, and pathogenic mechanisms, including the role of some cytokines and growth factors in the development of the disease.

Original languageEnglish
JournalImmunologic Research
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Bullous Pemphigoid
Mucous Membrane
Epithelium
Cicatrix
Immunomodulation
Conjunctiva
Vision Disorders
Blister
Disease Progression
Intercellular Signaling Peptides and Proteins
Pharmacology
Cytokines
Biopsy
Therapeutics

Keywords

  • Autoimmune disease
  • Cytokines
  • Fibrosis
  • Growth factors
  • Mucous membrane pemphigoid
  • Ocular pemphigoid

ASJC Scopus subject areas

  • Immunology

Cite this

Taurone, S., Spoletini, M., Ralli, M., Gobbi, P., Artico, M., Imre, L., ... Micera, A. (2019). Ocular mucous membrane pemphigoid: a review. Immunologic Research. https://doi.org/10.1007/s12026-019-09087-7

Ocular mucous membrane pemphigoid : a review. / Taurone, Samanta; Spoletini, Marialuisa; Ralli, Massimo; Gobbi, Pietro; Artico, Marco; Imre, Laszlò; Czakò, Cecília; Kovács, I.; Greco, Antonio; Micera, Alessandra.

In: Immunologic Research, 01.01.2019.

Research output: Contribution to journalReview article

Taurone, S, Spoletini, M, Ralli, M, Gobbi, P, Artico, M, Imre, L, Czakò, C, Kovács, I, Greco, A & Micera, A 2019, 'Ocular mucous membrane pemphigoid: a review', Immunologic Research. https://doi.org/10.1007/s12026-019-09087-7
Taurone S, Spoletini M, Ralli M, Gobbi P, Artico M, Imre L et al. Ocular mucous membrane pemphigoid: a review. Immunologic Research. 2019 Jan 1. https://doi.org/10.1007/s12026-019-09087-7
Taurone, Samanta ; Spoletini, Marialuisa ; Ralli, Massimo ; Gobbi, Pietro ; Artico, Marco ; Imre, Laszlò ; Czakò, Cecília ; Kovács, I. ; Greco, Antonio ; Micera, Alessandra. / Ocular mucous membrane pemphigoid : a review. In: Immunologic Research. 2019.
@article{224e4b43355f4bf9aa50d7e91a870f1e,
title = "Ocular mucous membrane pemphigoid: a review",
abstract = "Ocular mucous membrane pemphigoid (MMP) is a rare, immuno-mediated chronic progressive condition of the conjunctiva characterized by blisters developing from sub-epithelial tissue through disruption of the adhesions between the conjunctival epithelium and the sub-epithelium. Patients with ocular MMP, in many cases, develop profound conjunctival scarring and visual impairment. Furthermore, ocular MMP may lead to a progressive secondary corneal vascularization and to corneal opacification. Ocular MMP is difficult to diagnose during the initial stages because of false negatives during biopsy and variability in the clinical presentation. Most of the current pharmacological treatments aim to control the inflammatory response to reduce the progressive tissue remodeling which leads to the formation of a fibrotic scar. The course and prognosis of ocular MMP depend on the severity and progression of the disease after systemic immunomodulatory therapy. The aim of this review is to provide a comprehensive analysis of the current literature on established and emerging concepts in ocular MMP, with special attention to its clinical presentation, diagnosis, treatment, and pathogenic mechanisms, including the role of some cytokines and growth factors in the development of the disease.",
keywords = "Autoimmune disease, Cytokines, Fibrosis, Growth factors, Mucous membrane pemphigoid, Ocular pemphigoid",
author = "Samanta Taurone and Marialuisa Spoletini and Massimo Ralli and Pietro Gobbi and Marco Artico and Laszl{\`o} Imre and Cec{\'i}lia Czak{\`o} and I. Kov{\'a}cs and Antonio Greco and Alessandra Micera",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12026-019-09087-7",
language = "English",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",

}

TY - JOUR

T1 - Ocular mucous membrane pemphigoid

T2 - a review

AU - Taurone, Samanta

AU - Spoletini, Marialuisa

AU - Ralli, Massimo

AU - Gobbi, Pietro

AU - Artico, Marco

AU - Imre, Laszlò

AU - Czakò, Cecília

AU - Kovács, I.

AU - Greco, Antonio

AU - Micera, Alessandra

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Ocular mucous membrane pemphigoid (MMP) is a rare, immuno-mediated chronic progressive condition of the conjunctiva characterized by blisters developing from sub-epithelial tissue through disruption of the adhesions between the conjunctival epithelium and the sub-epithelium. Patients with ocular MMP, in many cases, develop profound conjunctival scarring and visual impairment. Furthermore, ocular MMP may lead to a progressive secondary corneal vascularization and to corneal opacification. Ocular MMP is difficult to diagnose during the initial stages because of false negatives during biopsy and variability in the clinical presentation. Most of the current pharmacological treatments aim to control the inflammatory response to reduce the progressive tissue remodeling which leads to the formation of a fibrotic scar. The course and prognosis of ocular MMP depend on the severity and progression of the disease after systemic immunomodulatory therapy. The aim of this review is to provide a comprehensive analysis of the current literature on established and emerging concepts in ocular MMP, with special attention to its clinical presentation, diagnosis, treatment, and pathogenic mechanisms, including the role of some cytokines and growth factors in the development of the disease.

AB - Ocular mucous membrane pemphigoid (MMP) is a rare, immuno-mediated chronic progressive condition of the conjunctiva characterized by blisters developing from sub-epithelial tissue through disruption of the adhesions between the conjunctival epithelium and the sub-epithelium. Patients with ocular MMP, in many cases, develop profound conjunctival scarring and visual impairment. Furthermore, ocular MMP may lead to a progressive secondary corneal vascularization and to corneal opacification. Ocular MMP is difficult to diagnose during the initial stages because of false negatives during biopsy and variability in the clinical presentation. Most of the current pharmacological treatments aim to control the inflammatory response to reduce the progressive tissue remodeling which leads to the formation of a fibrotic scar. The course and prognosis of ocular MMP depend on the severity and progression of the disease after systemic immunomodulatory therapy. The aim of this review is to provide a comprehensive analysis of the current literature on established and emerging concepts in ocular MMP, with special attention to its clinical presentation, diagnosis, treatment, and pathogenic mechanisms, including the role of some cytokines and growth factors in the development of the disease.

KW - Autoimmune disease

KW - Cytokines

KW - Fibrosis

KW - Growth factors

KW - Mucous membrane pemphigoid

KW - Ocular pemphigoid

UR - http://www.scopus.com/inward/record.url?scp=85069441615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069441615&partnerID=8YFLogxK

U2 - 10.1007/s12026-019-09087-7

DO - 10.1007/s12026-019-09087-7

M3 - Review article

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

ER -